Geraldine Dawson
Director, Duke Center for Autism & Brain Development
William Cleland Distinguished Professor
Overview
Geraldine Dawson is Professor, Departments of Psychiatry and Behavioral Sciences, Pediatrics, and Psychology and Neuroscience and Director of the Duke Center for Autism and Brain Development at Duke University, North Carolina. Dawson is Past President of the International Society for Autism Research. She serves as a member of the NIH Interagency Autism Coordinating Committee (IACC) which develops the federal strategic plan for autism research, services, and policy. Dawson is a licensed practicing clinical psychologist and scientist, having published extensively on early detection and treatment of autism and brain development. Dawson is a Fellow of the Association for Psychological Science and the American Psychological Association, and is Associate Editor or on editorial boards of four scientific journals. Dawson’s awards include a Lifetime Achievement Award from the Association for Psychological Science for outstanding contributions to the area of applied psychological research that addresses a critical problem in society at large.
Selected Grants
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care awarded by National Institutes of Health (Principal Investigator). 2019 to 2024
Scalable Computational Platform For Active Closed-Loop Behavioral Coding in Autism Spectrum Disorder awarded by National Institutes of Health (Co-Principal Investigator). 2019 to 2023
Duke CTSA (TL1) awarded by National Institutes of Health (Mentor). 2018 to 2023
Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and early treatment awarded by National Institutes of Health (Principal Investigator). 2017 to 2022
Digital Behavioral Outcome Measures for Autism awarded by (Co-Principal Investigator). 2019 to 2022
Marcus Foundation Phase II MSC ASD awarded by (Co-Principal Investigator). 2019 to 2022
Tailoring treatment targets for early autism intervention in Africa awarded by National Institutes of Health (Co Investigator). 2019 to 2021
Pilot Study to Improve Access to Early Intervention for Autism in Africa awarded by National Institutes of Health (Mentor). 2015 to 2020
1/5-The Autism Biomarkers Consortium for Clinical Trials awarded by Yale University (Principal Investigator). 2015 to 2020
Scalable Quantitative Video Analysis for Online Phenotyping, Early Screening, and Symptom Monitoring for Autism Spectrum Disorders awarded by (Co-Principal Investigator). 2017 to 2018
Pages
McPartland, J. C., et al. “Autism Spectrum Disorder.” Encyclopedia of Mental Health: Second Edition, 2016, pp. 124–30. Scopus, doi:10.1016/B978-0-12-397045-9.00230-5. Full Text
Filipek, P. A., et al. “The screening and diagnosis of autistic spectrum disorders.” The Science of Mental Health: Volume 2: Autism, 2013, pp. 11–56.
Dawson, G., and L. Sterling. “Autism Spectrum Disorders.” Encyclopedia of Infant and Early Childhood Development, vol. 1–3, 2008, pp. 137–43. Scopus, doi:10.1016/B978-012370877-9.00016-5. Full Text
Dawson, G., and K. Toth. “Autism Spectrum Disorders.” Developmental Psychopathology: Second Edition, vol. 3, 2006, pp. 317–57. Scopus, doi:10.1002/9780470939406.ch8. Full Text
Minshew, N. J., et al. “Neuropsychology and neurophysiology of autism spectrum disorders.” Understanding Autism: From Basic Neuroscience to Treatment, 2006, pp. 379–415.
Rogers, Sally J., et al. “A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual..” J Am Acad Child Adolesc Psychiatry, vol. 58, no. 9, Sept. 2019, pp. 853–65. Pubmed, doi:10.1016/j.jaac.2019.01.004. Full Text
Sabatos-DeVito, Maura, et al. “Methodological considerations in the use of Noldus EthoVision XT video tracking of children with autism in multi-site studies..” Biol Psychol, vol. 146, Sept. 2019. Pubmed, doi:10.1016/j.biopsycho.2019.05.012. Full Text
Franz, Lauren, and Geraldine Dawson. “Implementing early intervention for autism spectrum disorder: a global perspective..” Pediatr Med, vol. 2, Aug. 2019. Pubmed, doi:10.21037/pm.2019.07.09. Full Text Open Access Copy
Davlantis, Katherine S., et al. “A novel method for measuring learning opportunities provided by parents to young children with autism spectrum disorder..” Autism, vol. 23, no. 6, Aug. 2019, pp. 1563–74. Pubmed, doi:10.1177/1362361318817303. Full Text
Carpenter, Kimberly L. H., et al. “Sensory Over-Responsivity: An Early Risk Factor for Anxiety and Behavioral Challenges in Young Children..” Journal of Abnormal Child Psychology, vol. 47, no. 6, June 2019, pp. 1075–88. Epmc, doi:10.1007/s10802-018-0502-y. Full Text
Amaral, David G., et al. “Gaps in Current Autism Research: The Thoughts of the Autism Research Editorial Board and Associate Editors..” Autism Res, vol. 12, no. 5, May 2019, pp. 700–14. Pubmed, doi:10.1002/aur.2101. Full Text
Campbell, Kathleen, et al. “Computer vision analysis captures atypical attention in toddlers with autism..” Autism, vol. 23, no. 3, Apr. 2019, pp. 619–28. Pubmed, doi:10.1177/1362361318766247. Full Text
Dawson, Geraldine, and Guillermo Sapiro. “Potential for Digital Behavioral Measurement Tools to Transform the Detection and Diagnosis of Autism Spectrum Disorder..” Jama Pediatr, vol. 173, no. 4, Apr. 2019, pp. 305–06. Pubmed, doi:10.1001/jamapediatrics.2018.5269. Full Text
Dawson, Geraldine. “Inappropriate Use of the Term Autism as Analogy..” Jama Pediatr, vol. 173, no. 4, Apr. 2019. Pubmed, doi:10.1001/jamapediatrics.2018.5421. Full Text
Yerys, Benjamin E., et al. “Brief Report: Pilot Study of a Novel Interactive Digital Treatment to Improve Cognitive Control in Children with Autism Spectrum Disorder and Co-occurring ADHD Symptoms..” J Autism Dev Disord, vol. 49, no. 4, Apr. 2019, pp. 1727–37. Pubmed, doi:10.1007/s10803-018-3856-7. Full Text
Pages
Naples, Adam, et al. “EEG AND PUPILLARY RESPONSE IN CHILDREN WITH AUTISM: RESULTS FROM THE AUTISM BIOMARKERS CONSORTIUM FOR CLINICAL TRIALS INTERIM ANALYSIS.” Psychophysiology, vol. 56, WILEY, 2019, pp. S20–S20.
Ressler, B., et al. “Meeting the demands of msc production for clinical studies.” Cytotherapy, vol. 21, no. 5, Elsevier BV, 2019, pp. S81–82. Crossref, doi:10.1016/j.jcyt.2019.03.496. Full Text
Kurtzberg, J., et al. “MANUFACTURING OF ALLOGENEIC HUMAN CORD TISSUE MESENCHYMAL STROMAL CELLS: INITIAL RESULTS OF A PHASE I CLINICAL TRIAL IN CHILDREN WITH AUTISM SPECTRUM DISORDER.” Cytotherapy, vol. 20, no. 5, ELSEVIER SCI LTD, 2018, pp. S44–S44.
Li, Y., et al. “Extracting relationships by multi-domain matching.” Advances in Neural Information Processing Systems, vol. 2018-December, 2018, pp. 6798–809.
Carpenter, Kimberly, et al. “Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism.” Neuropsychopharmacology, vol. 42, NATURE PUBLISHING GROUP, 2017, pp. S495–96.
Pandina, G., et al. “Prospective, observational cohort study of JAKE (TM), an autism knowledge.” European Neuropsychopharmacology, vol. 27, ELSEVIER SCIENCE BV, 2017, pp. S1118–S1118.
Li, Y., et al. “Targeting EEG/LFP synchrony with neural nets.” Advances in Neural Information Processing Systems, vol. 2017-December, 2017, pp. 4621–31.
Neuhaus, Emily, et al. “FACE PROCESSING AND PARENT ANXIETY DURING EARLY CHILDHOOD INTERACT TO PREDICT ADOLESCENT ANXIETY IN AUTISM SPECTRUM DISORDER.” Psychophysiology, vol. 52, WILEY-BLACKWELL, 2015, pp. S101–S101.